LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
9.52 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: three recent Strong Buy ratings (100% consensus) with high historical win rates. Fund‑flow score is 7.65 (good), showing net inflows across size segments, especially small and large investors. Overall capital interest aligns with the positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-23
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate80.0%
Is money flowing into or out of LXRX?
- LXRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 9.52/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
